Document:

Executive Officer Severance Plan and Summary Plan Description.

 Exhibit 10.93 
 INVITROGEN CORPORATION’S 
 EXECUTIVE OFFICER SEVERANCE PLAN 
 AND 
 SUMMARY PLAN DESCRIPTION

  
 EFFECTIVE FEBRUARY 28, 2006 

 TABLE OF CONTENTS 
  

					
	 	  	 	  	Page
	 I.
	  	INTRODUCTION	  	1
			
	 II.
	  	ELIGIBILITY	  	1
			
	 III.
	  	SEVERANCE BENEFITS	  	2
			
	 IV.
	  	CLAIMS PROCEDURE	  	4
			
	 V.
	  	STATEMENT OF RIGHTS UNDER THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 (“ERISA”)	  	4
			
	 VI.
	  	AMENDMENT AND TERMINATION	  	5
			
	 VII.
	  	EMPLOYMENT RIGHTS	  	5
			
	 VIII.
	  	NONALIENATION OF BENEFITS	  	5
			
	 IX.
	  	GOVERNING LAW	  	5
			
	 X.
	  	GENERAL INFORMATION	  	5

 INVITROGEN CORPORATION’S 
 EXECUTIVE OFFICER SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION 
  

	I.	INTRODUCTION 

 Invitrogen Corporation
(“Invitrogen”) hereby adopts the Invitrogen Corporation Executive Officer Severance Plan and Summary Plan Description (the “Plan”), to provide severance benefits to eligible executives of Invitrogen whose employment is terminated
involuntarily under certain circumstances. The Plan is effective as of February 28, 2006, and supersedes any and all other severance plans, policies or practices, including but not limited to the Invitrogen Corporation Executive Officer
Severance Plan and Summary Plan Description, effective November 1, 2004. All benefit determinations under the Plan and interpretation of Plan provisions will be made by Invitrogen (or its designee) in its sole discretion as Plan Administrator.
The Plan is described in further detail below. 
  

	II.	ELIGIBILITY 

 Any executive currently working for
Invitrogen at the executive officer level (EL-2 and above) whose employment is terminated involuntarily is eligible for severance benefits described in Section III of this Plan, PROVIDED each of the following requirements is met: 
 1. The termination of employment is involuntary. The termination is involuntary if initiated by Invitrogen. 
 2. The termination is not due to retirement, death or disability of the executive. 
 3. The termination of employment is not for “cause” (as defined below). Employment is terminated involuntarily if the
termination action is initiated by Invitrogen and is not for cause. For purposes of the Plan, “cause” shall mean the following: 
 a. Acts or omissions constituting gross negligence, recklessness or willful misconduct on the part of the executive with respect to his/her obligations or otherwise relating to the business of Invitrogen, its
affiliates or customers; 
 b. The executive’s material breach of the Information and Technology Agreement; 

c. The executive’s conviction or entry of a plea of nolo contendere for fraud, misappropriation or embezzlement, or any felony or
crime of moral turpitude; or 
 d. The executive’s willful neglect of duties as determined in the sole and exclusive
discretion of Invitrogen. 
 Invitrogen, as Plan Administrator, will, in its sole discretion, determine if a termination of employment is for
“cause.” 
 4. The executive is not a temporary employee or a new hire who has not yet started to work on a
regular, full-time or part-time basis. 
  

 - 1 - 

 5. The executive is not covered under any other severance-type plan, policy,
arrangement or agreement that provides severance payments and benefits more favorable in the aggregate to those provided herein. If any such plan, policy, arrangement or agreement exists, the executive will receive payments and benefits pursuant
to that plan, policy, arrangement or agreement and shall not receive any of the severance payments and benefits described herein. If the severance payments and benefits provided under any other severance-type plan, policy, arrangement or agreement
are less favorable in the aggregate than the severance payments and benefits described in this Plan, than the executive will be eligible for the severance payments and benefits described herein, provided that all of the remainder of the eligibility
requirements are met. In no case, will the executive receive severance payments and benefits under any other such severance-type plan, policy, arrangement or agreement and this Plan. 
 6. The executive has not agreed in writing to waive severance benefits under this Plan or otherwise payable from Invitrogen.

 7. The executive signs and does not revoke a Confidential Separation Agreement and General Release of All Claims
(“Separation Agreement”) in a form acceptable to Invitrogen. Such Separation Agreement provides for a full, general release of all claims, known and unknown, suspected and unsuspected, by the eligible executive, as well as agreements
pertaining to nondisparagement, confidentiality, return of Invitrogen property, among other provisions and may contain, at Invitrogen’s sole and absolute discretion, a 12-month covenant not to compete and a 12-month nonsolicitation of customers
and/or employees provision, all of which shall be drafted to comply with applicable governing law. 
 8. The executive
has returned all Invitrogen property and equipment. 
 A terminated executive must satisfy all of the requirements set forth above
in order to receive severance benefits under the Plan. Eligibility for severance benefits under the Plan will be determined by Invitrogen upon an eligible executive’s termination of employment. Invitrogen has full power and authority to
interpret the provisions of the Plan and render decisions on eligibility for benefits. If Invitrogen determines that an eligible executive satisfies all of the eligibility conditions described above, the executive will receive severance benefits
calculated in accordance with Section III below. The severance benefits will be paid following the eligible executive’s termination of employment in accordance with the terms set forth below and in the Separation Agreement. 
  

	III.	SEVERANCE BENEFITS 

 A. Severance Pay and Benefits.
The following severance pay and benefits are payable under this Plan: 
 1. Severance Pay. The amount of severance pay
provided to an eligible involuntarily terminated executive under this Plan is twelve (12) months of base salary. 
 The amount of
severance payable to an eligible executive shall be based upon the executive’s regular weekly base salary in effect immediately before his/her termination of employment. The weekly salary shall be determined without regard to any overtime,
bonuses, fringe benefits, reimbursements or other irregular payments. 
  

 - 2 - 

 Severance will be paid in accordance with one of the following two payment schedules, to be determined by
Invitrogen at its discretion at the time of the executive’s termination: 
 (a) over time in accordance with
Invitrogen’s regular payroll practices, provided that all such payments are made by March 15 of the year following the year in which the termination occurs; or 
 (b) all severance payments will be delayed six (6) months from the date of termination, at which time a lump sum payment equal to six
(6) months of the executive’s base salary, plus an interest payment calculated using the six-month Libor rate, will be made. The remaining severance payments (equal to six (6) months of the executive’s base salary) will be made
thereafter in accordance with Invitrogen’s regular payroll practices. 
 2. Incentive Bonus. The executive will
receive his/her target incentive bonus under Invitrogen’s Incentive Compensation Plan (“ICP”) for the year in which the termination occurred, prorated to the date of termination, payable in a lump sum within thirty (30) days of
the date of termination if the executive is paid severance according to the schedule described in section III.A.1.a or in six months if the executive is paid severance according to the schedule described in section III.A.1.b. An incentive payment
made after six months will include an interest payment calculated using the six-month Libor rate. 
 3. Outplacement
Services. Invitrogen will provide nine (9) months of outplacement assistance through a designated service provider to eligible executives. In no event shall an eligible executive receive cash or other severance benefits in lieu of
outplacement assistance. 
 4. Continuation of Group Health Insurance Coverage. Invitrogen will also pay for the
monthly premiums required to continue an eligible executive’s group health insurance coverage for a period of twelve (12) months. Continuation of group health insurance coverage will be on the same terms as during the executive’s
employment, provided the executive elects to continue such benefits and remains eligible to receive such benefits in accordance with the applicable provisions of the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”). If an
eligible executive’s group health insurance coverage included his/her dependents immediately prior to the executive’s Separation Date, such dependents shall also be covered at Invitrogen’s expense. 
 All severance payments and benefits will be made less applicable taxes and withholdings. 
 B. No Separate Fund. All severance benefits payable under the Plan are payable from Invitrogen’s general assets. There is no separate trust
or fund established for the payment of severance benefits under the Plan. All amounts shall be less all appropriate deductions, including federal, state and local withholding taxes. 
 C. Additional Benefits. Invitrogen reserves the right to pay benefits in addition to those required by the Plan based on special circumstances.
Each exception will be considered unique and not precedent-setting. Payment of additional amounts or provision of additional benefits will be subject to such terms and conditions as Invitrogen may determine. All such determinations shall be made by
Invitrogen in its sole and absolute discretion. 
  

 - 3 - 

	IV.	CLAIMS PROCEDURE 

 Severance benefits under this Plan will
automatically be paid to executives who qualify for such benefits. An executive who believes that he or she is entitled to severance benefits under this Plan that have not been provided should file a claim with Invitrogen’s Human Resources
Department. The claim must be in writing. If the claim is denied, written notice of the denial will be provided within 90 days (180 days if additional processing time is required) of the initial receipt of the claim. Such notice will include an
explanation of the factors on which the denial is based (including specific reasons for the denial and specific references to plan provisions) and what, if any, additional information is needed to support the claim or to request a review of the
decision. Further review of the claim and access to relevant plan information may be obtained by filing a written request for review with the Human Resources Department within 60 days of receiving the denial. The decision on review will be made no
later than 60 days (120 days if additional processing time is required) after the request for review is received and shall contain an explanation of the right to file suit under ERISA Section 502(a) with respect to a claim denied upon such
review. 
  

	V.	STATEMENT OF RIGHTS UNDER THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 (“ERISA”) 

 The Plan is an employee benefit plan subject to the provisions of the Employee Retirement Income Security Act of 1974 (ERISA). The following statement is
required by ERISA: 
 ERISA provides that all employees who may become eligible for benefits under the Plan shall be entitled to: 

 

	 	1.	Examine, without charge, at Invitrogen’s offices all documents relating to the Plan. 

  

	 	2.	Obtain copies of all documents relating to the Plan upon written request. A reasonable charge may be imposed for the copies. 

 In addition to creating rights for employees, ERISA imposes duties upon the people who are responsible for the operation of the employee benefit plan.
These people, called “fiduciaries” of the plan, have a duty to act prudently and in the interest of all employees. No one, including Invitrogen, or any other person, may fire you or otherwise discriminate against you in any way to prevent
you from obtaining a benefit or exercising your rights under ERISA. If your claim for a benefit is denied in whole or in part, you must receive a written explanation of the reason for the denial. You have the right to have Invitrogen review and
reconsider your claim. Under ERISA, there are steps you can take to enforce the above rights. For instance, if you request materials from Invitrogen and do not receive them within 30 days, you may file a suit in federal court and the court may
require Invitrogen to provide the materials and pay you a penalty of up to $110 per day until you receive the materials, unless the materials were not sent because of reasons beyond the control of Invitrogen. If you have a claim for benefits which
is denied or ignored, in whole or in part, you may file suit in a state or federal court. If you are discriminated against for asserting your rights, you may seek assistance from the U.S. Department of Labor, or you may file suit in a federal
court. The court will decide who should pay court costs and legal fees. If you are successful, the court may order the person you 

  

 - 4 - 

 
have sued to pay these costs and fees. If you lose, the court may order you to pay these costs and fees, for example, if it finds your claim is frivolous. If
you have any questions about the Plan, you should contact Invitrogen (Human Resources). If you have any questions about this statement or about your rights under ERISA, you should contact the nearest Area Office of the Employee Benefits Security
Administration, U.S. Department of Labor listed in your telephone directory or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue, NW,
Washington, DC 20210. 
  

	VI.	AMENDMENT AND TERMINATION 

 Invitrogen, by action of its
Board of Directors or by action of any committee appointed by the Board to administer the Plan, reserves the right to terminate or amend the Plan at any time and in any manner in its sole discretion. No executive shall have any vested interest in
severance benefits payable under this Plan prior to satisfying all of the terms and conditions for payment of benefits under this Plan. 
  

	VII.	EMPLOYMENT RIGHTS 

 Nothing in this Plan shall have any
effect on Invitrogen’s right to terminate an executive, with or without cause, at any time (subject to the terms of any written employment contract between the executive and Invitrogen). The payment of severance benefits under this Plan does
not extend an executive’s term of employment. 
  

	VIII.	NONALIENATION OF BENEFITS 

 No benefit under the Plan may
be assigned, transferred, pledged as security for indebtedness or otherwise encumbered by any eligible executive or subject to any legal process for the payment of any claim against an eligible executive. 
  

	IX.	GOVERNING LAW 

 This Plan shall be governed by and
construed in accordance with the laws of the State of California to the extent such laws are not preempted by ERISA. 
  

	X.	GENERAL INFORMATION 

  

			
	Employer and Plan Administrator Name:	  	 Invitrogen Corporation
 1600 Faraday Avenue
 Carlsbad, California 92008

		
	Employer Identification Number:	  	33 037 3077
		
	Plan Number:	  	10011
		
	Type of Plan:	  	The Plan is an unfunded welfare benefit plan providing severance benefits
		
	Agent For Service of Process:	  	Corporate Creations International Inc. 11380 Prosperity Farms Road #221E Palm Beach Gardens, Florida 33410
		
	Plan Year:	  	Calendar

  

 - 5 -Form of Restricted Stock Agreement under 2004 Equity Incentive Plan

 Exhibit 10.2.2 
  
 RESTRICTED STOCK AGREEMENT 
  
 This RESTRICTED STOCK AGREEMENT (this “Agreement”) is made and entered into as of
                    , 20         between NETLOGIC MICROSYSTEMS,
INC., a Delaware corporation (the “Company”), and                      (“Grantee”).

  
 R E C I T A L S: 
  
 A. The Company’s 2004 Equity Incentive Plan (the
“Plan”) authorizes the sale and issuance of restricted shares of common stock upon terms and conditions determined by the compensation committee of the board of directors of the Company. 
  
 B. The shares of common stock subject to this Agreement are being offered and
issued to Grantee pursuant to the plan by an action by such compensation committee and effective                          ,
            . 
  
 NOW, THEREFORE, in consideration of the mutual covenants exchanged, the parties agree as follows: 
  

1.    Grant of Shares. 
  
 (a) Grant of Shares. The Company agrees to issue to Grantee, and Grantee agrees to accept from the
Company,              shares (the “Shares”) of the Company’s common stock, par value $.01 per share (the “Common Stock”). All of the
Shares shall be subject to the covenants, conditions and restrictions set forth in this Agreement and the terms of the Plan, as in effect from time to time. 
  
 (b) Closing and Delivery. The issuance of the Shares shall be effective immediately upon the action of the compensation committee
of the board of directors of the Company, subject to Grantee’s execution of this Agreement. As soon as practicable, the issuance of the Shares shall be recorded in book form as of the Closing Date and shall be subject to the custody and control
of the Escrow Agent, as defined below, and after Shares vest, as provided in Section 2(b), the Company shall direct its transfer agent to deposit such Shares with [            
] (the “Designated Broker”). 
  
 (c) Rights as Stockholder. Effective as of the date of this Agreement, Grantee shall have all of the rights or privileges of a stockholder of the Company in respect of the Shares, including with respect to
voting such Shares and receipt of dividends and distributions on such Shares. If any such dividends or distributions are paid in shares of Company Common Stock, the Shares shall be subject to the same restrictions on transferability and
forfeitability as the Shares with respect to which they were paid. 
  
 2.    Vesting Restriction. 
  
 (a) Shares Subject To Option To Reacquire. Grantee hereby grants to the Company the option to reacquire all or part of the grant of Shares set forth in Section 1(a) automatically upon the occurrence set
forth in subsection (c), but only to the extent such Shares have not vested as provided in subsection (b) or subsection (d). 
  
 (b) Vesting Dates. The Shares shall vest as follows: [vesting schedule] 
  
 Shares that have not vested are referred to herein as
“Unvested Shares,” and Shares which have vested are referred to herein as “Vested Shares.” All Unvested Shares are forfeitable upon the conditions stated in subsection (c). 
  
 (c) Occurrence Permitting Reacquisition of Shares.
The Company may reacquire all Unvested Shares if during the term of this Agreement Grantee shall cease to be employed by the Company (including a parent or subsidiary of the Company) or serve as
             or consultant of the Company (including a parent or subsidiary of the Company) for any reason, or no reason, with or without cause, including involuntary termination,
death or disability (except as provided in (d), below). Upon the occurrence of such event, the Company shall automatically reacquire all Unvested Shares for surrender and cancellation by Grantee effective upon notice to Grantee and the Escrow Agent,
as defined below, or Grantee’s permitted transferee 

 
or legal representative, as the case may be, within 90 days after the date thereof. Upon receipt of such notice, Grantee shall (i) no longer have any
rights with respect to the Unvested Shares so surrendered and canceled, and (ii) agrees to promptly deliver to the Company, for cancellation, all stock certificates or other documentation evidencing such Shares within the possession, custody or
control of Grantee or any agent of Grantee. 
  
 (d) Optional: Notwithstanding anything in subsection (c) to the contrary in the event of Grantee’s Involuntary Termination of employment within 12 months after the date of this Agreement the vesting of the Shares shall be
accelerated such that 50% of the total number of Shares will so vest as of the effective date of such Involuntary Termination. An “Involuntary Termination” is one that occurs by reason of dismissal for any reason other than
Misconduct or of voluntary resignation following: (i) a change in position that materially reduces the level of Grantee’s responsibility, (ii) a material reduction in Grantee’s base salary, or (iii) relocation by more than
50 miles from the principal office where Grantee is located at the commencement of employment with the Company; provided that (ii) and (iii) will apply only if Grantee has not consented to the change or relocation.
“Misconduct” shall mean the commission of any act of fraud, embezzlement or dishonesty by Grantee, any unauthorized use or disclosure by such person of confidential information or trade secrets of the Company (or any Parent
or Subsidiary), or any other intentional misconduct by such person adversely affecting the business affairs of the Company (or any Parent or Subsidiary) in a material manner. The foregoing definition shall not be deemed to be inclusive of all the
acts or omissions which the Company (or any Parent or Subsidiary) may consider as grounds for the dismissal or discharge of Grantee. 
  
 3.    Adjustments. If, from time to time during the term of this Agreement and to the extent
provided under Section 8.1 of the Plan: (i) there is any stock dividend, distribution or dividend of cash or property, stock split, or other change in the character or amount of any of the outstanding securities of the Company; or
(ii) there is any consolidation, merger or sale of all, or substantially all, of the assets of the Company; then in such event, any and all new, substituted or additional securities, cash or other property that Grantee receives or to which
Grantee is entitled by reason of Grantee’s ownership of the Shares shall be immediately subject to the provisions of Section 2 and be included in the word “Shares” for all purposes with the same force and effect as the Shares
presently subject to this Agreement. 
  
 4.    Transfer Restrictions; Legends. 
  
 (a) Until the applicable Shares vest they shall not be sold, transferred, assigned, pledged or hypothecated in any way (whether by
operation of law or otherwise) and shall not be subject to sale under execution, attachment or similar process. Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this award, or of any right or privilege conferred
hereby, or upon any attempted sale under any execution, attachment or similar process, this award and the rights and privileges conferred hereby immediately shall become null and void. 
  
 (b) Endorsement on Certificates. The certificates representing the Shares subject to this Agreement
shall be endorsed with a legend substantially in the following form: 
  
 THE SHARES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF A RESTRICTED STOCK AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER OR SUCH HOLDER’S PREDECESSOR IN INTEREST, A COPY OF WHICH IS
ON FILE WITH THE SECRETARY OF THE COMPANY. THE AGREEMENT MAY BE INSPECTED AT THE PRINCIPAL OFFICE OF THE COMPANY DURING NORMAL BUSINESS HOURS. 
  
 [THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT ARE HELD BY AN “AFFILIATE” OF THE COMPANY AS THAT TERM IS DEFINED IN RULE 144 UNDER THE
SECURITIES ACT OF 1933, AS AMENDED. NO SALE OR DISTRIBUTION OF THESE SECURITIES MAY BE EFFECTED UNLESS THE SALE OR OTHER DISTRIBUTION IS EFFECTED PURSUANT TO RULE 144(e).] [FOR AFFILIATES OF THE COMPANY ONLY] 
  

 2 

 (c) Other Legends. The certificates representing the Shares granted pursuant to
this Agreement shall also be endorsed with any other legends required by the law or other applicable state blue sky laws. 
  
 (d) Stop-Transfer Notices. Grantee agrees that, in order to ensure compliance with the restrictions imposed on the Shares under
this Agreement, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records.

  
 (e) Refusal to Transfer. The Company
shall not be required (i) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (ii) to treat as owner of such Shares or to accord the right to vote or
pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred notwithstanding such purchaser’s or transferee’s lack of knowledge of such provisions. 
  
 (f) Termination of All Restrictions. In the event the
restrictions imposed by this Agreement shall be terminated, a new certificate or certificates representing the Shares shall be issued, on request, without the legends referred to in Sections 4(b) and 4(c). 
  
 (g) Securities Law Legends. Any transfer or sale of
the Shares is further subject to all restrictions on transfer imposed by state or federal securities laws. Accordingly, it is understood and agreed that the certificates representing the Shares shall bear any legends required by such state or
federal securities laws. 
  
 5.    Consent of Spouse/Domestic Partner. If Grantee is married on the date of this Agreement, Grantee’s spouse or domestic partner shall execute a Consent of Spouse/Domestic Partner in
the form attached hereto as Attachment 1 hereto (a “Consent of Spouse”), effective on the date hereof. Such Consent of Spouse shall not be deemed to confer or convey to the spouse or domestic partner any
rights in the Shares that do not otherwise exist by operation of law or by agreement of the parties. If Grantee should marry or remarry subsequent to the date of this Agreement, Grantee shall within 30 days thereafter obtain his or her new spouse or
domestic partner’s acknowledgment of and consent to the existence and binding effect of all restrictions contained in this Agreement by signing a Consent of Spouse. 
  
 6.    Grantee’s Representations. Grantee hereby represents and warrants
to the Company as follows: 
  
 (a) Restricted
Securities. Grantee understands and acknowledges that: 
  
 (i) the share certificate representing the Shares will be stamped with the legends specified in Section 4 hereof; and 
  
 (ii) the Company will make a notation in its records of the aforementioned restrictions on transfer and legends. 
  
 (b) Further Limitations on Disposition. Without in
any way limiting this or other representations set forth above, Grantee further agrees that Grantee shall in no event make any disposition of all or any portion of the Shares unless and until the Shares proposed to be transferred are no longer
subject to reacquisition by the Company pursuant to Section 2, if still applicable at the time of the proposed transfer. 
  
 7.    Escrow. As security for Grantee’s faithful performance of the terms of this Agreement and to
ensure the availability for delivery of Grantee’s Shares pursuant to Section 2(c), Grantee agrees, by accepting the Offer and signing this Agreement, to deliver to and deposit with the Company’s
[                    ], as Escrow Agent in this transaction (the “Escrow Agent”), two Stock Assignments duly endorsed (with
date and number of Shares blank) in the form attached hereto as Attachment 2 (the “Stock Assignment”), together with the certificate or certificates evidencing the Shares; which documents are to be held by
the Escrow Agent pursuant to the Joint Escrow Instructions set forth in Attachment 3 (the “Joint Escrow Instructions”). The Joint Escrow Instructions shall be delivered to the Escrow Agent at any
closing described under this Agreement. 
  
 8.    Compliance With Income Tax Laws. Grantee authorizes the Company to withhold in accordance with applicable law from any compensation payable to him or her any taxes required to be
withheld by federal, state 

  

 3 

 
or local laws as a result of the issuance of the Shares to Grantee. Furthermore, in the event of any determination that the Company has failed to withhold a
sum sufficient to pay all withholding taxes due in connection with the issuance of the Shares to Grantee, Grantee agrees to pay the Company the amount of such deficiency in cash within five days after receiving notice from the Company to do so,
whether or not Grantee is an employee of the Company at that time. 
  
 9.    Election Pursuant to Section 83(b) of Internal Revenue Code of 1986, as amended. Grantee shall be responsible for filing with the Internal Revenue Service an appropriate written
notice of election pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, if Grantee wishes to make such an election. Grantee shall notify the Company in writing if Grantee files such an election (a form of which is
attached hereto) within 30 days of the date of this Agreement. The Company intends, in the event it does not receive from Grantee evidence of such filing, to claim a tax deduction for any amount which would otherwise be taxable to Grantee in the
absence of such an election. GRANTEE ACKNOWLEDGES THAT IT IS GRANTEE’S SOLE RESPONSIBILITY AND NOT THE COMPANY’S TO FILE TIMELY THE ELECTION UNDER SECTION 83(b), EVEN IF GRANTEE REQUESTS THE COMPANY OR ITS REPRESENTATIVE TO MAKE THIS
FILING ON GRANTEE’S BEHALF. GRANTEE FURTHER ACKNOWLEDGES THAT, IF HE OR SHE MAKES THE ELECTION UNDER SECTION 83(b), THE VALUE OF THE SHARES AT THE CLOSING DATE WILL HAVE TO BE REPORTED IN THE 83(b) ELECTION AND AS INCOME ON GRANTEE’S 2006
FEDERAL AND STATE INCOME TAX RETURNS. 
  
 10.    Not Employment Rights. Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a parent or subsidiary of the Company, to terminate
Grantee’s employment relationship, for any reason, with or without cause. Grantee understands and acknowledges that (i) his or her employment with the Company is for an unspecified duration and constitutes “at-will” employment,
(ii) any representation to the contrary is unauthorized and not valid unless obtained in writing and signed by the President of the Company, and (iii) his or her employment relationship with the Company may be terminated at any time, with
or without cause or for any or no cause, at the option either of the Company or Grantee, with or without notice. 
  
 11.    Governing Law. This Agreement and all acts and transactions pursuant hereto and the
rights and obligations of the parties hereto shall be governed, and construed and interpreted in accordance with the laws of California without giving effect to its principles of conflicts of laws. 
  
 12.    Entire
Agreement. This Agreement sets forth the entire agreement and understanding of the parties relating to the subject matter of this Agreement and merges all prior discussions between them. No modification of or amendment
to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in a writing signed by the parties to this Agreement. The failure by either party to enforce any of such party’s rights under this Agreement shall
not be construed as a waiver of any rights of such party in the absence of such party’s signed written waiver. 
  
 13.    Severability. If one or more provisions of this Agreement are held to be unenforceable under
applicable law, the parties agree to renegotiate such provision in good faith. In the event the parties cannot reach a mutually agreeable and enforceable replacement for such provision, (i) such provision shall be excluded from this Agreement,
(ii) the balance of the Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of the Agreement shall be enforceable in accordance with its terms. 
  
 14.    Construction. This Agreement is the result of negotiations between and has been reviewed by each of the parties hereto and their respective counsel, if any; accordingly,
this Agreement shall be deemed to be the product of all of the parties hereto, and no ambiguity shall be construed in favor of or against any one of the parties hereto. 
  
 15.    Notices. All notices and other communications required or permitted
hereunder shall be in writing and shall be deemed effectively given upon personal delivery or on the day sent by electronic mail or facsimile 

  

 4 

 
transmission if a true and correct copy is sent the same day by first class mail, postage prepaid, by registered or certified mail or by dispatch by an
internationally recognized express courier service. Notice sent solely by first class mail, postage prepaid, by registered or certified mail or by dispatch by an internationally recognized express courier service shall be deemed effectively given on
the second day following the day sent. Each such notice or other communication shall be sent, (i) if to Grantee, to his or her addresses and numbers set forth on the signature page of this Agreement and (ii) if to the Company, to its
principal place of business, to the attention of it Chief Financial Offier, or to such other address or facsimile number or electronic mail address, as the case may be, as the addressee may have designated by notice to the addressor. 
  
 16.    Counterparts. This Agreement may be executed counterparts. 
  
 17.    Successors and Assigns. The rights and benefits of this Agreement shall
inure to the benefit of, and be enforceable by the Company’s successors and assigns. The rights and obligations of Grantee under this Agreement may be assigned only with the prior written consent of the Company. 
  
 IN WITNESS WHEREOF, the parties have executed this Agreement on the date
first above written. 
  

					
	NETLOGIC MICROSYSTEMS, INC.	 	 	 	GRANTEE
			
	 By:                                      
                                        
                
	 	 	 	                                       
                                        
                       

			
	 Its:                                      
                                        
                 
	 	 	 	 
	 	 	 	 	Mailing Address:
	 	 	 	 	                                      
                                        
                       
	 	 	 	 	                                      
                                        
                       
	 	 	 	 	Telephone:                                     
                                        
   
	 	 	 	 	Fax:                                      
                                        
               
	 	 	 	 	E-Mail                                     
                                        
           

  

 5 

 DESCRIPTION OF SECTION 83(b) ELECTION 
  
 When an employee receives stock of his or her employer and the stock is forfeitable and not transferable until specified
vesting requirements have been fulfilled (“unvested” stock), the employee’s income tax consequences are determined under Section 83 of the Internal Revenue Code. 
  
 The general rule of Section 83 is that the employee has a taxable event at the time the employer’s repurchase
right lapses (i.e., when the stock “vests”). At that time, the employee has ordinary income equal to the excess (the “delta”) of the fair market value of the stock at the time of vesting over the price paid by the
employee for the stock. If the stock has appreciated between the time of purchase and the time of vesting, the appreciation will be ordinary income to the employee (as will any delta that existed when the stock was purchased). The holding period of
the stock commences when the stock vests and any subsequent appreciation will be capital gain. If the stock is held for more than one year from the vesting date any capital gain will be long term capital gain. 
  
 This tax treatment may be viewed as undesirable for two reasons. First, the
appreciation of the shares between the purchase date and the vesting date will be ordinary income to the employee. Ordinary income is taxed at federal rates up to 35%, while the maximum federal rate on long-term capital gain generally is 15%, but
may be 10% or 5% under certain circumstances. Second, the taxable event that occurs on the vesting date may not coincide with a liquidity event, such as the sale of the corporation. In the absence of a liquidity event, the employee may have a
taxable event but no cash with which to pay the taxes. 
  
 Pursuant to Section 83(b) of the Internal Revenue Code an employee who receives unvested stock may elect to be taxed at the time the stock is purchased. If the Section 83(b) election is made, the employee will have ordinary income
equal to the delta at the time of purchase (rather than at the time the stock vests). If the purchase price is equal to fair market value at the time of purchase (i.e., the delta is zero), there is no income and, consequently, no tax. The holding
period commences at the date of purchase and any subsequent appreciation will be capital gain. If the one-year holding period is satisfied, all of the gain will be long term capital gain. Thus, the Section 83(b) election can result in all of
the employee’s gain being capital gain and no tax being due until the stock is sold by the employee. 
  
 The Section 83(b) election must be filed by the employee and it must be filed with the Internal Revenue Service Center where the employee files his
or her income tax returns. The election must be filed not later than 30 days after the stock is purchased or otherwise transferred to the employee. There is no relief for failing to timely file the election. A copy of the election must be
provided to the employer and a copy must be included with the employee’s tax return for the taxable year in which the stock is purchased. The Section 83(b) election must be filed even if the purchase price is equal to the fair market value
of the stock at time of purchase (i.e., even if the delta is zero). 
  
 NOTE: The foregoing is not a complete or thorough discussion of income and other tax consequences of the employee’s purchase of stock and the Company is not hereby rendering any such advice. Grantees are strongly urged to
consult their own tax advisors. Stock acquired from the exercise of stock options may subject the employee to additional and different income and tax consequences, none of which are discussed above. 
  

 6 

 ELECTION UNDER SECTION 83(b) 
 OF THE INTERNAL REVENUE CODE OF 1986 
  
 The undersigned taxpayer hereby elects, pursuant to Sections 55 and 83(b) of the Internal Revenue Code of 1986, as amended (the
“Code”), to include in taxpayer’s gross income or alternative minimum taxable income (to the extent applicable under Section 83), as applicable, for the current taxable year, the amount of any income that may be
taxable to taxpayer in connection with taxpayer’s receipt of the property described below: 
  

	1.	The name, address, taxpayer identification number and taxable year of the undersigned are as follows: 

  

	 	NAME	OF
TAXPAYER:                                      
                                        
                                   

  

	 	NAME	OF TAXPAYER’S SPOUSE/DOMESTIC PARTNER:
                                        
             

  

	 	ADDRESS:                                     
                                        
                                        
                   	

  

	 	TAXPAYER	IDENTIFICATION
NO.:                                       
                                        
              

  

	 	SPOUSE/DOMESTIC	PARTNER IDENTIFICATION
NO.:                                       
                    

  

	 	TAXABLE	YEAR:                                     
                                        
                                        
        

  

	2.	The property with respect to which the election is made is described as follows: 

  

	    	shares of the NetLogic Microsystems, Inc. (the “Company”) received pursuant to a Restricted Stock Agreement, dated
                    , 20        , between the Company and the taxpayer (the
“Agreement”). 

  

	3.	The date on which the property was transferred is:                     ,
20         

  

	4.	The property is subject to the following restrictions: 

  

	    	The shares are subject to forfeiture and acquisition by the Company, or its successor or assignee, if the taxpayer ceases to be employed by the Company (including a parent or
subsidiary of the Company) or serve as a director or consultant of the Company (including a parent or subsidiary of the Company) for any reason, or no reason, with or without cause, including involuntary termination, death or disability, which right
lapses over time as to 50% of the total shares on the first anniversary of the date of the Agreement, as to 25% of the shares six months thereafter and as to the last 25% of the shares on the second anniversary of the Agreement.

  

	5.	The fair market value at the time of transfer, determined without regard to any restriction other than a restriction which by its terms will never lapse, of such property is:

  

	6.	The amount (if any) paid for such property: 

  
 The undersigned has submitted a copy of this statement to the person for whom the services were performed in connection with the undersigned’s
receipt of the above-described property. The transferee of such property is the person performing the services in connection with the transfer of said property. 
  

The undersigned understands that the foregoing election may not be revoked except with the consent of the Commissioner. 
  

			
	 Dated:
	  	

	 	  	  

  
 The undersigned spouse/domestic
partner of taxpayer joins in this election. 
  

			
	 Dated:
	  	

	 	  	 Spouse/Domestic Partner of Taxpayer

  

 7 

 Attachment 1 
  
 to Restricted Stock Agreement 
  
 CONSENT OF SPOUSE/DOMESTIC PARTNER 
  
 I,                     ,
[spouse/domestic partner] of                      acknowledge that I have read the Restricted Stock Agreement dated as of
            , 20        , to which this Consent is attached as Attachment 1 (the “Agreement”) and that I know its contents. I
am aware that by its provisions (a) NetLogic Microsystems, Inc. (the “Company”) has the option to reacquire certain Shares of the Company which my [spouse/domestic partner] owns pursuant to the Agreement including any
interest I might have therein, if my [spouse/domestic partner] shall cease to be employed by the Company (including a parent or subsidiary of the Company) or serve as a director or consultant of the Company (including a parent or subsidiary of the
Company) for any reason, or no reason, with or without cause, including involuntary termination, death or disability; and (b) certain other restrictions are imposed upon the sale or other disposition of the Shares. 
  
 I agree that my interest, if any, in the Shares subject to the Agreement
shall be irrevocably bound by the Agreement and further understand and agree that any community property interest I may have in the Shares shall be similarly bound by the Agreement. 
  
 I agree to the option to reacquire described in Section 2 of the Agreement and I hereby consent to any transfer of the
Shares in accordance with the provisions of the Agreement. 
  
 I am aware that the legal, financial and related matters contained in the Agreement are complex and that I am free to seek independent professional guidance or counsel with respect to this Consent. I have either sought such guidance or
counsel or determined after reviewing the Agreement carefully that I will waive such right. 
  
 Dated as of             , 20        . 
  

	
	
 Spouse/Domestic Partner
  

	

	 Print Name

  

 8 

 Attachment 2 
  
 to Restricted Stock Agreement 
  
 ASSIGNMENT SEPARATE FROM CERTIFICATE 
  
 FOR VALUE RECEIVED,
                     hereby sells, assigns and transfers unto             ,
             (            ) shares of the Common Stock of NetLogic Microsystems, Inc., a Delaware corporation, standing in the
undersigned’s name on the books of said corporation represented by book entry lot No.              or Certificate No.
            , and does hereby irrevocably constitute and appoint said corporation as the undersigned’s agent and attorney-in-fact to transfer the said stock on the books of the said
corporation with full power of substitution in the premises. 
  

					
	 Dated: 
	 	 	 	                                       
                                        
                   

	 	 	 	 	  
                                       
                                        
                   

  

 9 

 ASSIGNMENT SEPARATE FROM CERTIFICATE 
  
 FOR VALUE RECEIVED,              hereby sells, assigns and
transfers unto                     ,
                     (            ) shares of the Common Stock of NetLogic Microsystems,
Inc., a Delaware corporation, standing in the undersigned’s name on the books of said corporation represented by book entry lot No.              or Certificate No.
            , and does hereby irrevocably constitute and appoint said corporation as the undersigned’s agent and attorney-in-fact to transfer the said stock on the books of the said
corporation with full power of substitution in the premises. 
  

					
	 Dated: 
	 	 	 	                                       
                                        
                   

	 	 	 	 	  
                                       
                                        
                   

 Attachment 3 
  
 to Restricted Stock Agreement 
  
 JOINT ESCROW INSTRUCTIONS 
  
             ,
20         
  

	
	
 
	 NetLogic Microsystems, Inc.

	 1875 Charleston Road

	 Mountain View, CA 94043

  
 Dear Escrow Agent: 
  
 As Escrow Agent for both NetLogic Microsystems, Inc., a Delaware corporation
(the “Company”), and «name», the undersigned acquiror of common stock (the “Shares”) of the Company (the “Grantee”), you are hereby authorized and directed to
hold the documents delivered to you pursuant to the terms of that certain Restricted Stock Agreement (the “Agreement”), dated as of the date hereof, to which a copy of these Joint Escrow Instructions is attached as Attachment
3, in accordance with the following instructions: 
  
 1. In the
event the Company and/or any assignee of the Company (referred to collectively for convenience herein as the “Company”) shall reacquire the Shares pursuant to Section 2(c) of the Agreement, the Company shall give to
Grantee and you a written notice specifying the number of Shares reacquired. 
  
 2. Promptly after receipt of such notice, you are directed (a) to date the stock assignments necessary for the transfer in question, (b) to fill in the number of Shares being transferred, and (c) to
deliver same, together with the certificates evidencing the Shares to be transferred, to the Company. 
  
 3. Grantee irrevocably authorizes the Company to deposit with you any certificates evidencing the Shares to be held by you hereunder and any additions and
substitutions to said Shares as defined in the Agreement. Grantee does hereby irrevocably constitute and appoint you as his attorney-in-fact and agent for the term of this escrow to execute with respect to such securities all stock certificates,
stock assignments, or other documents necessary or appropriate to make such securities negotiable and complete any transaction herein contemplated. Subject to the provisions of this Section 3, Grantee shall exercise all rights and privileges of
a stockholder of the Company while the Shares are held by you. 
  
 4. This escrow shall terminate at such time as the Shares have vested according to Section 2(a) of the Agreement. 
  
 5. If at the time of termination of this escrow you should have in your possession any documents, securities, or other property belonging to Grantee, you
shall deliver all of same to Grantee and shall be discharged of all further obligations hereunder. 
  
 6. Your duties hereunder may be altered, amended, modified or revoked only by a writing signed by all of the parties hereto. 
  
 7. You shall be obligated only for the performance of such duties as are
specifically set forth herein and may rely and shall be protected in relying or refraining from acting on any instrument reasonably believed by you to be genuine and to have been signed or presented by the proper party or parties. You shall not be
personally liable for any act you may do or omit to do hereunder as Escrow Agent or as attorney-in-fact for Grantee while acting in good faith and in the exercise of your own good judgment, and any act done or omitted by you pursuant to the advice
of your own attorneys shall be conclusive evidence of such good faith. 
  
 8. You are hereby expressly authorized to disregard any and all warnings given by any of the parties hereto or by any other person or company, excepting only orders or process of courts of law, and are hereby expressly authorized to comply
with and obey orders, judgments or decrees of any court. In case you obey or comply with any such order, judgment or decree of any court, you shall not be liable to any of the parties hereto or to any 

  

 1 

 
other person, firm or company by reason of such compliance, notwithstanding any such order, judgment or decree being subsequently reversed, modified,
annulled, set aside, vacated or found to have been entered without jurisdiction. 
  
 9. You shall not be liable in any respect on account of any failure to confirm the identity, authorities or rights of the parties executing or delivering or purporting to execute or deliver the Agreement or any
documents or papers deposited or called for hereunder. 
  
 10. You
shall not be liable for the outlawing of any rights under the Statute of Limitations with respect to these Joint Escrow Instructions or any documents deposited with you. 
  
 11. You shall be entitled to employ such legal counsel and other experts as you may deem necessary or proper to advise you
in connection with your obligations hereunder, may rely upon the advice of such counsel, and may pay such counsel reasonable compensation therefore. 
  
 12. If you reasonably require other or further instructions in connection with these Joint Escrow Instructions or obligations in respect hereto, the
necessary parties hereto shall join in furnishing such instruments. 
  
 13. It is understood and agreed that should any dispute arise with respect to the delivery and/or ownership or rights of possession of the securities held by you hereunder, you are authorized and directed to retain in your possession
without liability to anyone all or any part of said securities until such dispute shall have been settled either by mutual written agreement of the parties concerned or by a final order, decree, or judgment of a court of competent jurisdiction after
the time for appeal has expired and no appeal has been perfected, but you shall be under no duty whatsoever to institute or defend any such proceedings. 
  
 14. All notices and other communications required or permitted hereunder shall be in writing and shall be deemed effectively given upon personal delivery
or on the day sent by electronic mail or facsimile transmission if a true and correct copy is sent the same day by first class mail, postage prepaid, by registered or certified mail or by dispatch by an internationally recognized express courier
service. Notice sent solely by first class mail, postage prepaid, by registered or certified mail or by dispatch by an internationally recognized express courier service shall be deemed effectively given on the second day following the day sent.
Each such notice or other communication shall be sent to the addresses and numbers set forth below, or to such other address or facsimile number or electronic mail address, as the case may be, as the addressee may have designated by notice to the
addressor. 
  

			
	 Company:
	  	 NetLogic Microsystems, Inc.
 1875 Charleston
Road
 Mountain View, CA 94043
 Attention:                                     
                                
 Telephone: (650)             -6676
 Facsimile:
(650)                                       
                  

		
	 Grantee:
	  	
  

  

 Telephone:                                     
                              
 Facsimile:                                     
                               
 E-Mail:                                     
                                     

		
	 Escrow Agent:
	  	
 NetLogic Microsystems, Inc.
 1875 Charleston Road
 Mountain View, CA 94043
 Attention:                                     
                                
 Telephone: (650)            -6676
 Facsimile:
(650)                                       
                  

  
  

 2 

 15. By signing these Joint Escrow Instructions, you become a party hereto only for the purpose of said
Joint Escrow Instructions; you do not become a party to the Agreement. 
  
 16. This instrument shall be binding upon and inure to the benefit of the parties hereto, and their respective successors and permitted assigns. 
  
 17. This instrument may be executed in counterparts and shall be governed by the laws of Delaware. 
  

			
	 Company:
	 	NETLOGIC MICROSYSTEMS, INC.
		
	 	 	By:                                      
                                        
                   
	 	 	                                      
                                        
                        
	 	 	                                      
                                        
                        
		
	 Escrow Agent:
	 	                                      
                                        
                          
		
	 	 	By:                                      
                                        
                   
	 	 	                                      
                                        
                        
	 	 	                                      
                                        
                        
		
	 Grantee:
	 	By:                                      
                                        
                   
	 	 	                                      
                                        
                        

  

 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}]]